All lobbying filings

TIBER CREEK GROUP

Lobbying for TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY) · Pharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $80,000.00 income · posted Apr 17, 2025

Official filing document

Bills named in this filing 5

HR 4818
Gas Pipeline Leak Detection and Repair Act of 2025
S 2407
Charting My Path for Future Success Act
S 150
Combating Cartels on Social Media Act of 2025
HR 6986
COLAs Don’t Count Act of 2026
S 3583
Upward Mobility Act of 2026

Lobbying activity 3

Medicare/Medicaid

Issues related to drug pricing and reimbursement for prescription drugs; Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169).

Health Issues

Issues related to drug pricing; Issues related to reimbursement of insulin products; H.R. 4818/S. 2407 - Treat and Reduce Obesity Act of 2023.

Issues related to intellectual property; S. 150 - Affordable Prescriptions for Patients Act of 2023; H.R. 6986/S. 3583 - A Bill to Address Patent Thickets.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.